Clinical Characteristics, Management, and Outcomes of Hospitalized Heart Failure in a Chinese Population—The Hong Kong Heart Failure Registry

Journal of Cardiac Failure

Volumn 22, Issue 8, 2016, Pages 600-608

  Hai, Jo Jo ^a   Chan, Pak Hei ^a   Huang, Duo ^a   Ho, Mei Han ^a   Ho, Chi Wai ^a   Cheung, Emmanuel ^a   Lau, Chu Pak ^a   Tse, Hung Fat ^a   Siu, Chung Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; clinical characteristics; Heart failure; outcomes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; MINERALOCORTICOID ANTAGONIST;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CAUCASIAN; CHINESE; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY DISEASE; CRACKLE; DYSPNEA; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART INFARCTION; HONG KONG; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; OBSERVATIONAL STUDY; PERIPHERAL EDEMA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; DISEASE MANAGEMENT; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGISTER; SURVIVAL RATE; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DISEASE MANAGEMENT; FEMALE; HEART FAILURE; HONG KONG; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; PREVALENCE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 84975466254     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.03.007     Document Type: Article

References (52)

1. 1 Braunwald, E., Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337 (1997), 1360–1369.
2. 2 Mosterd, A., Hoes, A.W., Clinical epidemiology of heart failure. Heart 93 (2007), 1137–1146.
3. 3 Mosterd, A., Hoes, A.W., de Bruyne, M.C., Deckers, J.W., Linker, D.T., Hofman, A., et al. Prevalence of heart failure and left ventricular dysfunction in the general population; the Rotterdam Study. Eur Heart J 20 (1999), 447–455.
4. 4 Cowie, M.R., Wood, D.A., Coats, A.J., Thompson, S.G., Poole-Wilson, P.A., Suresh, V., et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20 (1999), 421–428.
5. 5 Redfield, M.M., Jacobsen, S.J., Burnett, J.C. Jr, Mahoney, D.W., Bailey, K.R., Rodeheffer, R.J., Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003), 194–202.
6. 6 Francis, G.S., Benedict, C., Johnstone, D.E., Kirlin, P.C., Nicklas, J., Liang, C.S., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990), 1724–1729.
7. 7 Desai, A.S., Stevenson, L.W., Rehospitalization for heart failure: predict or prevent?. Circulation 126 (2012), 501–506.
8. 8 Roger, V.L., Weston, S.A., Redfield, M.M., Hellermann-Homan, J.P., Killian, J., Yawn, B.P., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004), 344–350.
9. 9 Tsuchihashi-Makaya, M., Hamaguchi, S., Kinugawa, S., Yokota, T., Goto, D., Yokoshiki, H., et al. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 73 (2009), 1893–1900.
10. 10 Shiba, N., Nochioka, K., Miura, M., Kohno, H., Shimokawa, H., Investigators, C., Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan–first report from the CHART-2 study. Circ J 75 (2011), 823–833.
11. 11 Sakata, Y., Shimokawa, H., Epidemiology of heart failure in Asia. Circ J 77 (2013), 2209–2217.
12. 12 Murray, C.J., Lopez, A.D., Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997), 1436–1442.
13. 13 Celermajer, D.S., Chow, C.K., Marijon, E., Anstey, N.M., Woo, K.S., Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol 60 (2012), 1207–1216.
14. 14 Wang, W., Hu, S.S., Kong, L.Z., Gao, R.L., Zhu, M.L., Wang, W.Y., et al. Summary of report on cardiovascular diseases in China, 2012. Biomed Environ Sci 27 (2014), 552–558.
15. 15 Siu, C.W., Yeung, C.Y., Lau, C.P., Kung, A.W., Tse, H.F., Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart 93 (2007), 483–487.
16. 16 Hinkle, L.E. Jr, Thaler, H.T., Clinical classification of cardiac deaths. Circulation 65 (1982), 457–464.
17. 17 Bleumink, G.S., Knetsch, A.M., Sturkenboom, M.C., Straus, S.M., Hofman, A., Deckers, J.W., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 25 (2004), 1614–1619.
18. 18 Kannel, W.B., Incidence and epidemiology of heart failure. Heart Fail Rev 5 (2000), 167–173.
19. 19 Senni, M., Tribouilloy, C.M., Rodeheffer, R.J., Jacobsen, S.J., Evans, J.M., Bailey, K.R., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98 (1998), 2282–2289.
20. 20 Goldberg, R.J., Spencer, F.A., Farmer, C., Meyer, T.E., Pezzella, S., Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med 118 (2005), 728–734.
21. 21 Bahrami, H., Kronmal, R., Bluemke, D.A., Olson, J., Shea, S., Liu, K., et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med 168 (2008), 2138–2145.
22. 22 Avery, C.L., Loehr, L.R., Baggett, C., Chang, P.P., Kucharska-Newton, A.M., Matsushita, K., et al. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 60 (2012), 1640–1646.
23. 23 Dunlay, S.M., Weston, S.A., Jacobsen, S.J., Roger, V.L., Risk factors for heart failure: a population-based case-control study. Am J Med 122 (2009), 1023–1028.
24. 24 Folsom, A.R., Yamagishi, K., Hozawa, A., Chambless, L.E., Atherosclerosis Risk in Communities Study I. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail 2 (2009), 11–17.
25. 25 Gottdiener, J.S., Arnold, A.M., Aurigemma, G.P., Polak, J.F., Tracy, R.P., Kitzman, D.W., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000), 1628–1637.
26. 26 Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B., Ho, K.K., The progression from hypertension to congestive heart failure. JAMA 275 (1996), 1557–1562.
27. 27 He, J., Ogden, L.G., Bazzano, L.A., Vupputuri, S., Loria, C., Whelton, P.K., Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161 (2001), 996–1002.
28. 28 Yin, Q., Zhao, Y., Li, J., Xue, Q., Wu, X., Gao, L., et al. The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing. Clin Cardiol 34 (2011), 442–446.
29. 29 Yu, S.B., Cui, H.Y., Qin, M., Kong, B., Liu, T., Zhao, Q.Y., et al. Characteristics of in-hospital patients with chronic heart failure in Hubei provincefrom 2000 to 2010. Zhonghua Xin Xue Guan Bing Za Zhi 39 (2011), 549–552.
30. 30 Woo, K.S., Donnan, S.P., Epidemiology of coronary arterial disease in the Chinese. Int J Cardiol 24 (1989), 83–93.
31. 31 Yusuf, S., Reddy, S., Ounpuu, S., Anand, S., Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104 (2001), 2746–2753.
32. 32 Pang, R.W., Tam, S., Janus, E.D., Siu, S.T., Ma, O.C., Lam, T.H., et al. Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment. Atherosclerosis 184 (2006), 438–445.
33. 33 Ramachandran, A., Snehalatha, C., Shetty, A.S., Nanditha, A., Trends in prevalence of diabetes in Asian countries. World J Diabetes 3 (2012), 110–117.
34. 34 Lao, X.Q., Xu, Y.J., Wong, M.C., Zhang, Y.H., Ma, W.J., Xu, X.J., et al. Hypertension prevalence, awareness, treatment, control and associated factors in a developing southern Chinese population: analysis of serial cross-sectional health survey data 2002–2010. Am J Hypertens 26 (2013), 1335–1345.
35. 35 Woo, K.S., Kong, S.M., Wai, K.H., The changing prevalence and pattern of acute rheumatic fever and rheumatic heart disease in Hong Kong—(1968–1978). Aust N Z J Med 13 (1983), 151–156.
36. 36 Yu, I.T., Li, W., Wong, T.W., Effects of age, period and cohort on acute myocardial infarction mortality in Hong Kong. Int J Cardiol 97 (2004), 63–68.
37. 37 Cheung, K.S., Yip, P.S., Trends in healthy life expectancy in Hong Kong SAR 1996–2008. Eur. J Ageing 7 (2010), 257–269.
38. 38 Sanderson, J.E., Chan, S.K., Chan, W.W., Hung, Y.T., Woo, K.S., The aetiology of heart failure in the Chinese population of Hong Kong—a prospective study of 730 consecutive patients. Int J Cardiol 51 (1995), 29–35.
39. 39 Brouwers, F.P., Hillege, H.L., van Gilst, W.H., van Veldhuisen, D.J., Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective. Curr Heart Fail Rep 9 (2012), 363–368.
40. 40 Fonarow, G.C., Stough, W.G., Abraham, W.T., Albert, N.M., Gheorghiade, M., Greenberg, B.H., et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50 (2007), 768–777.
41. 41 Nieminen, M.S., Brutsaert, D., Dickstein, K., Drexler, H., Follath, F., Harjola, V.P., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006), 2725–2736.
42. 42 Harjola, V.P., Follath, F., Nieminen, M.S., Brutsaert, D., Dickstein, K., Drexler, H., et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Feart Fail 12 (2010), 239–248.
43. 43 Levy, D., Kenchaiah, S., Larson, M.G., Benjamin, E.J., Kupka, M.J., Ho, K.K., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002), 1397–1402.
44. 44 Cowie, M.R., Wood, D.A., Coats, A.J., Thompson, S.G., Suresh, V., Poole-Wilson, P.A., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83 (2000), 505–510.
45. 45 Youn, Y.J., Yoo, B.S., Lee, J.W., Kim, J.Y., Han, S.W., Jeon, E.S., et al. Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry. Circ J 76 (2012), 1151–1158.
46. 46 Atherton, J.J., Hayward, C.S., Wan Ahmad, W.A., Kwok, B., Jorge, J., Hernandez, A.F., et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail 18 (2012), 82–88.
47. 47 Hogg, K., Swedberg, K., McMurray, J., Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43 (2004), 317–327.
48. 48 Lenzen, M.J., Scholte, O.P., Reimer, W.J., Boersma, E., Vantrimpont, P.J., Follath, F., et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25 (2004), 1214–1220.
49. 49 Bhatia, R.S., Tu, J.V., Lee, D.S., Austin, P.C., Fang, J., Haouzi, A., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006), 260–269.
50. 50 Owan, T.E., Hodge, D.O., Herges, R.M., Jacobsen, S.J., Roger, V.L., Redfield, M.M., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006), 251–259.
51. 51 Bursi, F., Weston, S.A., Redfield, M.M., Jacobsen, S.J., Pakhomov, S., Nkomo, V.T., et al. Systolic and diastolic heart failure in the community. JAMA 296 (2006), 2209–2216.
52. 52 Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E. Jr, Drazner, M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–239.